Literature DB >> 25414217

Unusual presentation of Sjögren's syndrome.

Aicha Bouraoui1, Syed Farhan Bari2, Julian Nash3, Kenneth Dawson3.   

Abstract

We present a case of a 67-year-old woman admitted from the neurology clinic for further investigations of progressive ataxia and sensory symptoms. Neurological examination showed reduced pinprick and absent vibration sensations in the lower limbs. Motor system examination was normal. Her antinuclear antibodies titre was 1:100 with positive Ro antibodies. Her initial nerve conduction studies were normal. However, the lower limb somatosensory-evoked potentials (SSEP) demonstrated impairment of central sensory conduction pathway. Rheumatology review revealed a history of fatigue and Sicca symptoms and her Schirmer's test was strongly positive. This lead to the diagnosis of ganglionopathy associated to Sjögren's syndrome. She had an excellent response to intravenous methylprednisolone followed by oral prednisolone and intravenous cyclophosphamide infusions. This case highlights that dorsal column involvement can precede the diagnosis of primary Sjögren's syndrome. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25414217      PMCID: PMC4244334          DOI: 10.1136/bcr-2014-206489

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  28 in total

1.  Sjögren's syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965.

Authors:  K J Bloch; W W Buchanan; M J Wohl; J J Bunim
Journal:  Medicine (Baltimore)       Date:  1992-11       Impact factor: 1.889

2.  The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement.

Authors:  H B Kaltreider; N Talal
Journal:  Ann Intern Med       Date:  1969-04       Impact factor: 25.391

Review 3.  Neurological manifestations of primary Sjogren's syndrome.

Authors:  Josiah Chai; Eric L Logigian
Journal:  Curr Opin Neurol       Date:  2010-10       Impact factor: 5.710

4.  Spinal cord magnetic resonance imaging demonstrates sensory neuronal involvement and clinical severity in neuronopathy associated with Sjögren's syndrome.

Authors:  K Mori; H Koike; K Misu; N Hattori; M Ichimura; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

5.  Peripheral neuropathy in primary Sjögren's syndrome.

Authors:  S I Mellgren; D L Conn; J C Stevens; P J Dyck
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

6.  Neurological complications of primary Sjögren's syndrome.

Authors:  C Lafitte; Z Amoura; P Cacoub; P Pradat-Diehl; C Picq; F Salachas; J M Léger; J C Piette; J Y Delattre
Journal:  J Neurol       Date:  2001-07       Impact factor: 4.849

7.  Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.

Authors:  B K Davidson; C A Kelly; I D Griffiths
Journal:  Rheumatology (Oxford)       Date:  1999-03       Impact factor: 7.580

Review 8.  [Ganglionopathies: evolving concept and ideas on management].

Authors:  T Kuntzer
Journal:  Rev Neurol (Paris)       Date:  2006-12       Impact factor: 2.607

Review 9.  Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies.

Authors:  Julius Birnbaum
Journal:  Neurologist       Date:  2010-09       Impact factor: 1.398

10.  Neurological Disorders in Primary Sjögren's Syndrome.

Authors:  Gabriel J Tobón; Jacques-Olivier Pers; Valérie Devauchelle-Pensec; Pierre Youinou
Journal:  Autoimmune Dis       Date:  2012-03-05
View more
  2 in total

1.  Parameters of Somatosensory Evoked Potentials in Patients with Primary Sjӧgren's Syndrome: Preliminary Results.

Authors:  Edyta Dziadkowiak; Agata Sebastian; Małgorzata Wieczorek; Elżbieta Kusińska; Marta Waliszewska-Prosół; Piotr Wiland; Maria Ejma
Journal:  J Immunol Res       Date:  2018-04-05       Impact factor: 4.818

2.  Progressive sensory ataxia and breast implant rupture, an uncommon presentation of a debated concept: a case report.

Authors:  Sofie Van Assche; Heleen Parmentier; Gaelle Varkas; Isabelle Peene; Sarah Herdewyn
Journal:  BMC Neurol       Date:  2022-09-24       Impact factor: 2.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.